Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 10/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 10/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2704131 | 0.91 | MPL (0.39) | KIF11 | |
| SCHEMBL10050386 | 0.91 | KIF11 (0.49) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL2706833 | 0.90 | MPL (0.37) | KIF11 | |
| SCHEMBL13373533 | 0.89 | KIF11 (0.47) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL2704058 | 0.86 | ESR1 (0.31) | — | |
| SCHEMBL10019274 | 0.86 | MPL (0.39) | — | |
| SCHEMBL2705681 | 0.85 | KIF11 (0.36) | KIF11 | |
| SCHEMBL13594194 | 0.85 | KIF11 (0.48) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL2706779 | 0.84 | CTSS (0.34) | CYP11B2CYP11B1 | |
| SCHEMBL2706736 | 0.83 | FEN1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088901-B2 | Azaindenofluorenedione derivative, material for organic electroluminescence device and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2012-01-03 | — | — | US | disclosed |
| US-20090315022-A1 | AZAINDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090315022-A1 | AZAINDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | CYP19A1, HSD17B2, AZI2 | KIF11 1815/4885CYP11B2 73/4885CYP11B1 92/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.